tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Chesney, 26 are a BUY (45.61%), 28 are a HOLD (49.12%), 3 are a SELL (5.26%).
Analyst Steve Chesney, currently employed at ATLANTIC EQUITIES, carries an average stock price target met ratio of 76.33% that have a potential upside of 31.37% achieved within 646 days.
Steve Chesney’s has documented 108 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 06-Feb-2024.
Analyst best performing recommendations are on CELG (CELGENE).
The best stock recommendation documented was for CELG (CELGENE) at 12/18/2015. The price target of $122 was fulfilled within 5 days with a profit of $11.86 (10.77%) receiving and performance score of 21.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Oct-2026
$310
$66.9 (27.52%)
$250
Hold Since 29-Sep-2022
$300
$56.9 (23.41%)
$185
9 days ago
(11-Oct-2026)
7/8 (87.5%)
$74.29 (32.91%)
329
Buy Since 16-May-2026
$270
$26.9 (11.07%)
$240
12 days ago
(08-Oct-2026)
15/41 (36.59%)
$44.29 (19.62%)
175
Buy Since 03-May-2022
$256
$12.9 (5.31%)
$260
13 days ago
(07-Oct-2026)
59/88 (67.05%)
$37.57 (17.20%)
179
Sell Since 16-Mar-2026
$175
$-68.1 (-28.01%)
$150
1 months 11 days ago
(09-Sep-2026)
0/3 (0%)
$-40.43 (-18.77%)
What Year was the first public recommendation made by Steve Chesney?
